FI896251A0 - Menetelmä uusien terapeuttisesti käyttökelpoisten pyratsolopyridiinijohdannaisten valmistamiseksi - Google Patents

Menetelmä uusien terapeuttisesti käyttökelpoisten pyratsolopyridiinijohdannaisten valmistamiseksi

Info

Publication number
FI896251A0
FI896251A0 FI896251A FI896251A FI896251A0 FI 896251 A0 FI896251 A0 FI 896251A0 FI 896251 A FI896251 A FI 896251A FI 896251 A FI896251 A FI 896251A FI 896251 A0 FI896251 A0 FI 896251A0
Authority
FI
Finland
Prior art keywords
preparation
therapeutically useful
new therapeutically
pyrazolopyridine derivatives
pyrazolopyridine
Prior art date
Application number
FI896251A
Other languages
English (en)
Swedish (sv)
Other versions
FI90870C (fi
FI90870B (fi
Inventor
Yoshihiro Fujikawa
Mikio Suzuki
Hiroshi Iwasaki
Mitsuaki Sakashita
Masaki Kitahara
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of FI896251A0 publication Critical patent/FI896251A0/fi
Application granted granted Critical
Publication of FI90870B publication Critical patent/FI90870B/fi
Publication of FI90870C publication Critical patent/FI90870C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Enzymes And Modification Thereof (AREA)
FI896251A 1988-04-26 1989-12-22 Menetelmä uusien terapeuttisesti käyttökelpoisten pyratsolopyridiinijohdannaisten valmistamiseksi FI90870C (fi)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP10309088 1988-04-26
JP10309088 1988-04-26
JP27143988 1988-10-27
JP27143988 1988-10-27
JP1684689 1989-01-26
JP1684689 1989-01-26
JP8900423 1989-04-19
PCT/JP1989/000423 WO1989010365A1 (en) 1988-04-26 1989-04-19 Pyrazolopyridine type mevalonolactones

Publications (3)

Publication Number Publication Date
FI896251A0 true FI896251A0 (fi) 1989-12-22
FI90870B FI90870B (fi) 1993-12-31
FI90870C FI90870C (fi) 1994-04-11

Family

ID=27281590

Family Applications (1)

Application Number Title Priority Date Filing Date
FI896251A FI90870C (fi) 1988-04-26 1989-12-22 Menetelmä uusien terapeuttisesti käyttökelpoisten pyratsolopyridiinijohdannaisten valmistamiseksi

Country Status (10)

Country Link
EP (1) EP0339358B1 (fi)
JP (1) JP2890448B2 (fi)
KR (1) KR970009222B1 (fi)
AT (1) ATE108450T1 (fi)
DE (1) DE68916685T2 (fi)
DK (1) DK659089D0 (fi)
FI (1) FI90870C (fi)
HU (1) HU203888B (fi)
NO (1) NO173501C (fi)
WO (1) WO1989010365A1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3130342B2 (ja) * 1991-10-04 2001-01-31 日産化学工業株式会社 動脈硬化性血管内膜肥厚抑制薬
CA2404669A1 (en) 2000-03-27 2001-10-04 Akiko Asakawa Condensed pyrazole derivatives, process for producing the same and use thereof
CA2691888A1 (en) * 2007-06-25 2008-12-31 Boehringer Ingelheim International Gmbh New chemical compounds
NZ585063A (en) 2007-11-02 2012-05-25 Vertex Pharma [1h- pyrazolo [3, 4-b] pyridine-4-yl] -phenyle or -pyridin-2-yle derivatives as protein kinase c-theta
EP2867236B1 (en) 2012-06-29 2017-06-14 Pfizer Inc Novel 4-(substituted-amino)-7h-pyrrolo[2,3-d]pyrimidines as lrrk2 inhibitors
CA2933767C (en) 2013-12-17 2018-11-06 Pfizer Inc. Novel 3,4-disubstituted-1h-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7h-pyrrolo[2,3-c]pyridazines as lrrk2 inhibitors
CN108137586B (zh) 2015-09-14 2021-04-13 辉瑞大药厂 作为LRRK2抑制剂的新颖咪唑并[4,5-c]喹啉和咪唑并[4,5-c][1,5]萘啶衍生物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984002131A1 (en) * 1982-11-22 1984-06-07 Sandoz Ag Analogs of mevalolactone and derivatives thereof, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
KR890001651B1 (ko) * 1984-06-22 1989-05-12 산도즈 파마슈티칼스 코포레이션 메발로노락톤의 피라졸 동족체 및 이의 유도체의 제조방법
US4761419A (en) * 1987-12-07 1988-08-02 Warner-Lambert Company 6-(((substituted)quinolinyl)ethyl)-and ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
US4822799A (en) * 1988-01-27 1989-04-18 Sandoz Pharm. Corp. Pyrazolopyridine analogs of mevalonolactone and derivatives thereof useful for inhibiting cholesterol biosynthesis in mammals

Also Published As

Publication number Publication date
DE68916685D1 (de) 1994-08-18
ATE108450T1 (de) 1994-07-15
HU203888B (en) 1991-10-28
JP2890448B2 (ja) 1999-05-17
HU892751D0 (en) 1990-03-28
DK659089A (da) 1989-12-22
WO1989010365A1 (en) 1989-11-02
DE68916685T2 (de) 1995-02-09
NO173501C (no) 1993-12-22
NO895165L (no) 1989-12-21
EP0339358B1 (en) 1994-07-13
KR900700480A (ko) 1990-08-13
KR970009222B1 (ko) 1997-06-09
FI90870C (fi) 1994-04-11
EP0339358A1 (en) 1989-11-02
JPH02275878A (ja) 1990-11-09
NO173501B (no) 1993-09-13
DK659089D0 (da) 1989-12-22
FI90870B (fi) 1993-12-31
NO895165D0 (no) 1989-12-21

Similar Documents

Publication Publication Date Title
FI875502A0 (fi) Morfolinoetylester av mykofenolsyra och dess derivat
NZ329374A (en) Tricyclic amide and urea derivatives, preparation thereof
ATE119774T1 (de) Imidazopyridinderivate und ihre verwendung.
AU6128590A (en) Novel compounds
CY2529B1 (en) New substituted azetidinones as anti-inflammatory and antidegenerative agents
NO931482D0 (no) Farmasoeytiske sammensetninger inneholdende quinolin- og quinazolinderivater og nye forbindelser for disse
NZ222399A (en) Cephalosporin derivatives; pharmaceutical compositions and processes for preparation
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
IL99829A0 (en) Heteroaroyl derivatives of monocyclic beta-lactams,pharmaceutical compositions containing the same and processes for the preparation thereof
NO173444C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 4-(4'- fluorfenyl-)-tienopyridin-derivater
FI896251A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyratsolopyridiinijohdannaisten valmistamiseksi
UA26893C2 (uk) Спосіб отримаhhя оhдасетроhу та його фармацевтичhо прийhятhих солей
ES2016017A6 (es) Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico.
PT89492A (pt) Processo de preparacao de novos derivados de tioformamida terapeuticamente activos
FI103885B1 (fi) Menetelmä terapeuttisesti aktiivisten 1-bentsyyli-4-fenyylipiperatsiinijohdannaisten valmistamiseksi ja välituotteina käyttökelpoisia yhdisteitä
NO306302B1 (no) FremgangsmÕte for fremstilling av krystallinsk loracarbef-monohydrat
AU657423B2 (en) Novel piperidine derivatives and process for preparation thereof
DK1264836T3 (da) Fremgangsmåde til fremstilling af indolopyrrolocarbaxolderivater
DK32789A (da) Derivat af antibiotikum a 42867
GR3001003T3 (en) Novel pregnane derivatives, processes for their preparaton and pharmaceutical compositions containing same

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: NISSAN CHEMICAL INDUSTRIES LTD.